China Medical System Holdings Limited (SEHK: 867)
Health Care · Pharmaceuticals · HK
HK$11.69
+2.45% today · -14.4% 1Y
China Medical System Holdings Limited (SEHK: 867) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.63B.
Over the last twelve months the share price has lost 14.4%, trading between 9.51 and 15.63.
Tweenvest scores China Medical System Holdings Limited across four factors: quality 78/100, value 39/100, growth 21/100, dividend 35/100. Its strongest factor is quality.
867 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.63B
- Revenue (TTM)
- $1.28B
- P/E
- 15.98
- EPS
- 0.63
- Dividend yield
- 2.98%
- Beta (5Y)
- 1.10
- 52-week high
- HK$15.63
- 52-week low
- HK$9.51
- Avg volume (3M)
- —
- Shares outstanding
- 2.43B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,193.00 | -3.30% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.36 | -1.02% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $152.89 | -2.28% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.29 | -1.00% |
Figures last refreshed Aug 18, 2026.